BAMS
IMMU

Bellevue Asset Management (Switzerland)’s Immunomedics Inc IMMU Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-300,000
Closed -$1.22M – 140
2015
Q2 		$1.22M Sell
300,000
-100,000
-25% -$409K 0.17% 105
2015
Q1 		$1.53M Buy
+400,000
New +$1.74M 0.21% 103

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s IMMU Position: Q3 2015 in Review

Bellevue Asset Management (Switzerland) sold out of Immunomedics Inc (IMMU) in Q3 2015, closing a stake of 300,000 shares — an estimated $1.22M sold.

Bellevue Asset Management (Switzerland) first reported a position in IMMU in Q1 2015 and held it in 2 quarters. The position peaked at $1.53M in Q1 2015. 79 funds tracked by Wall St. Rank hold IMMU as of Q3 2015.

  • Bellevue Asset Management (Switzerland) reported no remaining Immunomedics Inc position as of Q3 2015 after selling out during the quarter.
  • Bellevue Asset Management (Switzerland) sold 300,000 Immunomedics Inc shares in Q3 2015, an estimated $1.22M.
  • Bellevue Asset Management (Switzerland) first reported a position in Immunomedics Inc in Q1 2015 and held it in 2 quarters.
  • Bellevue Asset Management (Switzerland)'s Immunomedics Inc position peaked at $1.53M in Q1 2015.
  • 79 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q3 2015, filed 12 Nov 2015.